STATE STREET CORP - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 54 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$16,000
-33.3%
31,7000.0%0.00%
Q2 2020$24,000
-97.9%
31,700
-97.2%
0.00%
Q1 2020$1,150,000
-32.6%
1,127,484
+2.5%
0.00%
Q4 2019$1,705,000
+4.7%
1,099,951
+22.2%
0.00%
Q3 2019$1,629,000
+28.0%
900,256
+16.0%
0.00%
Q2 2019$1,273,000
+2133.3%
776,203
+2348.6%
0.00%
Q1 2019$57,000
-5.0%
31,7000.0%0.00%
Q4 2018$60,000
-46.9%
31,7000.0%0.00%
Q3 2018$113,000
+50.7%
31,700
-11.5%
0.00%
Q2 2018$75,00035,8000.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
CVI Holdings, LLC 1,484,714$2,658,0002.52%
ESSEX INVESTMENT MANAGEMENT CO LLC 549,750$984,0000.14%
BARD ASSOCIATES INC 88,184$158,0000.08%
EAM Investors, LLC 160,628$288,0000.07%
Regal Investment Advisors LLC 193,450$346,0000.07%
HighTower Advisors, LLC 5,284,838$9,460,0000.06%
HIGHLAND CAPITAL MANAGEMENT LP 545,000$976,0000.06%
Granite Point Capital Management, L.P. 329,000$589,0000.06%
Kore Private Wealth LLC 104,366$187,0000.04%
Verition Fund Management LLC 498,167$892,0000.04%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders